Terms: = Skin cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
27 results:
1. Effective Targeting of Melanoma Cells by Combination of mcl-1 and Bcl-2/Bcl-x
Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542429
[TBL] [Abstract] [Full Text] [Related]
2. Pancreatic Metastasectomy for Secondary Malignancy of the Pancreas: A Single-institution Experience.
Lee O; Yoon SK; Yoon SJ; Kim H; Han IW; Heo JS; Shin SH
Anticancer Res; 2024 Feb; 44(2):703-710. PubMed ID: 38307567
[TBL] [Abstract] [Full Text] [Related]
3. Survival Mechanisms of Metastatic Melanoma Cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System.
Obrador E; Salvador-Palmer R; López-Blanch R; Oriol-Caballo M; Moreno-Murciano P; Estrela JM
Cells; 2023 Jan; 12(3):. PubMed ID: 36766760
[TBL] [Abstract] [Full Text] [Related]
4. Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma.
Takahashi N; Tsukasaki K; Tanae K; Kohri M; Asou C; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Sato T; Kayano H; Arai E; Asou N
J Clin Exp Hematop; 2022 Mar; 62(1):18-24. PubMed ID: 34980789
[TBL] [Abstract] [Full Text] [Related]
5. Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death.
Bock FJ; Sedov E; Koren E; Koessinger AL; Cloix C; Zerbst D; Athineos D; Anand J; Campbell KJ; Blyth K; Fuchs Y; Tait SWG
Nat Commun; 2021 Nov; 12(1):6572. PubMed ID: 34772930
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review.
Feng D; Wang M; Zhang X; Wang J
Aktuelle Urol; 2021 Feb; 52(1):58-63. PubMed ID: 32932527
[TBL] [Abstract] [Full Text] [Related]
7. Influence of family history on risk of second primary cancers and survival in patients with squamous cell skin cancer.
Chattopadhyay S; Zheng G; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
Br J Dermatol; 2020 Sep; 183(3):488-494. PubMed ID: 31853941
[TBL] [Abstract] [Full Text] [Related]
8. Hereditary Leiomyomatosis and Renal Cell cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract] [Full Text] [Related]
9. [Extra uterine leiomyomatosis: Review of the literature].
Declas E; Lucot JP
Gynecol Obstet Fertil Senol; 2019; 47(7-8):582-590. PubMed ID: 31255836
[TBL] [Abstract] [Full Text] [Related]
10. Mantle Cell Lymphoma Involving skin: A Clinicopathologic Study of 37 Cases.
Kim DH; Medeiros LJ; Aung PP; Young KH; Miranda RN; Ok CY
Am J Surg Pathol; 2019 Oct; 43(10):1421-1428. PubMed ID: 31219818
[TBL] [Abstract] [Full Text] [Related]
11. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-Associated Renal Cell Carcinoma Showing High FDG Uptake.
Xiao Z; Dong A; Wang Y
Clin Nucl Med; 2019 May; 44(5):420-423. PubMed ID: 30762823
[TBL] [Abstract] [Full Text] [Related]
12. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
[TBL] [Abstract] [Full Text] [Related]
13. Case Study: Rare Case of Mantle Cell Lymphoma With Extranodal Involvement in the Foot.
Fu P; Mercado D; Malezhik V; Mannan AASR
J Foot Ankle Surg; 2017; 56(5):1104-1108. PubMed ID: 28842094
[TBL] [Abstract] [Full Text] [Related]
14. Hereditary leiomyomatosis and renal cell cancer syndrome associated renal cell carcinoma.
Adamane S; Desai S; Menon S
Indian J Pathol Microbiol; 2017; 60(1):108-110. PubMed ID: 28195105
[TBL] [Abstract] [Full Text] [Related]
15. Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma.
Guinard E; Legendre L; Kramkimel N; Avril MF; Chassaing N; Cabaret O; Guillaud-Bataille M; Mazereeuw Hautier J
Dermatology; 2016; 232(3):293-7. PubMed ID: 27161211
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
[TBL] [Abstract] [Full Text] [Related]
17. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract] [Full Text] [Related]
18. ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer.
Choe MH; Min JW; Jeon HB; Cho DH; Oh JS; Lee HG; Hwang SG; An S; Han YH; Kim JS
Oncotarget; 2015 Feb; 6(5):2654-66. PubMed ID: 25605256
[TBL] [Abstract] [Full Text] [Related]
19. Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics.
Frederick DT; Salas Fragomeni RA; Schalck A; Ferreiro-Neira I; Hoff T; Cooper ZA; Haq R; Panka DJ; Kwong LN; Davies MA; Cusack JC; Flaherty KT; Fisher DE; Mier JW; Wargo JA; Sullivan RJ
PLoS One; 2014; 9(7):e101286. PubMed ID: 24983357
[TBL] [Abstract] [Full Text] [Related]
20. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
[TBL] [Abstract] [Full Text] [Related]
[Next]
